Tadalafil

NDC 16729-372 · Accord Healthcare Inc.

Generic nameTadalafil

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)TADALAFIL

Strength20 mg/1

Pharmacologic classPhosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]

Marketing categoryANDA

Packages

16729-372-10 — 30 TABLET, FILM COATED in 1 BOTTLE (16729-372-10)

16729-372-16 — 500 TABLET, FILM COATED in 1 BOTTLE (16729-372-16)

FDA lists these products with the same active ingredient.

13668-567 — TADALAFIL, 13668-568 — TADALAFIL, 13668-581 — TADALAFIL, 16714-074 — Tadalafil, 16714-075 — Tadalafil, 16714-076 — Tadalafil, 16714-077 — Tadalafil, 16729-369 — Tadalafil, 16729-370 — Tadalafil, 16729-371 — Tadalafil, 24979-727 — Tadalafil, 24979-728 — Tadalafil, 24979-729 — Tadalafil, 24979-730 — Tadalafil, 27241-111 — Tadalafil, 27241-112 — Tadalafil, 27241-113 — Tadalafil, 27241-114 — Tadalafil, 27241-123 — Tadalafil, 29300-286 — tadalafil, +230 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.